Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.

Analytics

Biotechnology

Ambagon Therapeutics

Scott Clarke

Peter Dudek

Tanja Meyer

Zhen Zhang

Thomas Marty

Neil Richardson

Dhara Amin

Maarten Altelaar

Christian Ottmann

Nancy Pryer

The Directors Team at Ambagon Therapeutics oversees strategic planning, decision-making, and management related to the development of small molecule cancer drugs. They ensure alignment with the company's mission, drive key projects forward, and provide leadership across various departmental functions to advance the company’s therapeutic discoveries.

Directors Team

Scientific Research Team

Scientific Advisory Team

Directors Team

About

Team members

Other teams at Ambagon Therapeutics

Scientific Research Team

Scientific Advisory Team